Health Boards
Sat-13-08-2022, 10:33 AM
Update: The U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis.
|
Tremfya going after psoriatic arthritis
|
Sun-14-08-2022, 18:18 PM
To be honest, non of the IL23s seem to work for the back, at least not for me.
 (Sun-14-08-2022, 18:18 PM)mataribot Wrote: To be honest, non of the IL23s seem to work for the back, at least not for me. I can imagine that. Personally I have the idea that the IL23’s are more related to psoriasis and that the IL17’s and IL17A’s are more related to Psoriatic Arthritis. Considering all the examples over here on psoriasisclub. |
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Bimzelx vs Skyrizi study for psoriatic arthritis | Fred | 0 | 512 |
Mon-30-09-2024, 14:22 PM Last Post: Fred |
|
|
Effectiveness of Tremfya in patients with facial and/or genital psoriasis | Fred | 0 | 845 |
Fri-28-06-2024, 13:10 PM Last Post: Fred |
|
|
Tremfya and sexual impairment | Fred | 7 | 4,003 |
Thu-20-06-2024, 03:12 AM Last Post: mataribot |
|
|
Tremfya and serum protein levels | Fred | 0 | 849 |
Thu-09-05-2024, 19:48 PM Last Post: Fred |
|
|
Persistence and effectiveness of Tremfya in Spanish psoriasis patients | Fred | 0 | 1,702 |
Sat-12-08-2023, 13:53 PM Last Post: Fred |
Users browsing this thread: 6 Guest(s)